Allarity Therapeutics, Inc. (ALLR) vs Pasithea Therapeutics Corp. (KTTA)
A side-by-side comparison of Allarity Therapeutics, Inc. and Pasithea Therapeutics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$0.98HealthcareDelayed quote: Oct 6, 2026, 10:37 AM EDT
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 10:37 AM EDT
Total return — ALLR vs KTTA
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)KTTA -98.6% (-57.2%/yr)KTTA compounded faster over this window
Log scale — wide-divergence pair
ALLR KTTA
ALLR vs KTTA: by the numbers
- •ALLR is the larger company ($16M vs $15M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | KTTA |
|---|---|---|
| P/S ratio | 45.21 | N/A |
| P/B ratio | 4.41 | 0.30 |
Profitability
| Metric | ALLR | KTTA |
|---|---|---|
| Gross margin | 107.54% | 0.00% |
| Operating margin | -3939.06% | 0.00% |
| Net margin | -3575.07% | 0.00% |
| ROE | -348.81% | -42.72% |
| ROIC | -41.81% | -48.04% |
Growth (annualized)
| Metric | ALLR | KTTA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -61.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.